Importance of the Diversity Site Assessment Tool (DSAT) in Relation to Best Practices in Enrolling Diverse Populations in Clinical Trials Among European Countries
Strengthen your research site’s preparedness for more diverse patient engagement in your trials. This session will provide a better understanding of best practices for sites to work with diverse populations. Learn how the DSAT can be used implement diverse capable practices at sites.
Diana Foster, PhD, Vice President, Diversity, Inclusion & Equity, SCRS, USA
Brandon Doyle, MBA, Associate Director Site Alliances, Parexel, USA
Operationalizing Your Site as a Business: Successful Site Models
We know one size does not fit all, so understanding how to set your site up as a business can look different. Join us for an informative session presenting models of successful sites. Attendees will leave this discussion knowing what components should be measured, how to set effective staffing, and how to establish business goals.
Piotr Sawicki, Head of Clinical Trials Department, CMP, Poland
Rachael Buck, PhD, Director, Project Management, Accellacare, UK
Edward Czerwinski, Senior Medical Director, FutureMeds, Poland
Nicola McIntosh, Vice President, Head of Commerical, AES, UK
Innovative Methods for Patient Recruitment & Retention in Oncology Research
There is no shortage of questions when it comes to oncology clinical trial referral and recruitment. Is “fear of losing the study participant” validated? Am I capturing the right referral chains for my portfolio? Is there a role for study participant advocacy groups? What is the role in oncology trial recruitment for advanced practice providers? Hear answers to common questions as well as successful experiences and best practices in building and expanding patient referral networks.
Paul Duffy, MA, RGN, PGd, Head, Clinical Site Partnerships, MSD, UK
Graham Howieson, Senior Director, Business Development, Greenphire, UK
Estrella Soriano, PhD, Director, Clinical Site Operations, Pfizer, Spain
Jai Singh, VP, Site Growth & Adoption, OneStudyTeam, USA
Decentralized Clinical Trials (DCTs) – Just the Facts!
Sometimes you just want to know the facts, plain and simple. We will break down where your site’s obligations lie when working with outsourced vendors, as well as the licensed staff working on the trial but are not working for you. We will also shine the light on gray areas of DCTs so you have all the information you need.
Lisa Bjornestad, Vice President Clinical Operations and Growth, DM Clinical Research, USA
Janusz Kabata, Md,PhD, MBA, CEO, GP4research, Poland
Adam Levy, MRes Pharmaceutical and Biomedical Sciences, Senior Solutions Specialist, Medidata, a Dassault Systémes company, UK
Managing Expectations with Sponsors & CROs
Managing expectations will yield better contracts as well as make your site run more effectively. Learn how to work with industry stakeholders so you have helpful, respectful, and professional communication while ensuring you manage realistic site expectations.
Steve Satek, MBA, CCO, Flourish Research, USA
Rupi Bancil, Senior Vice President, Operations & Expansion, Care Access, UK
Jeff Repper, Executive VP, Strategic Site, Transformative Pharmaceutical Solutions, LLC, USA
Claudia Schaub, Site Solutions Director, Strategic Networks, Parexel International GmbH, Germany
Iwona Tongbhoyai, Vice President of Operations, FutureMeds, Germany